Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cytek Biosciences stock

Learn how to easily invest in Cytek Biosciences stock.

Cytek Biosciences Inc is a medical devices business based in the US. Cytek Biosciences shares (CTKB) are listed on the NASDAQ and all prices are listed in US Dollars. Cytek Biosciences employs 555 staff and has a trailing 12-month revenue of around $148.5 million.

How to buy shares in Cytek Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CTKB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Cytek Biosciences stock price (NASDAQ: CTKB)

Use our graph to track the performance of CTKB stocks over time.

Cytek Biosciences shares at a glance

Information last updated 2022-09-19.
Latest market close$12.58
52-week range$7.38 - $26.50
50-day moving average $13.12
200-day moving average $12.71
Wall St. target price$16.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.03

Buy Cytek Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cytek Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytek Biosciences price performance over time

Historical closes compared with the close of $12.58 from 2022-09-23

1 week (2022-09-16) -5.34%
1 month (2022-08-24) -5.84%
3 months (2022-06-24) 13.23%
6 months (2022-03-24) 20.73%
1 year (2021-09-24) -47.82%
2 years (2020-09-20) N/A
3 years (2019-09-20) N/A
5 years (2017-09-20) N/A

Is Cytek Biosciences stock undervalued or overvalued?

Valuing Cytek Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cytek Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cytek Biosciences's EBITDA

Cytek Biosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.5 million.

The EBITDA is a measure of a Cytek Biosciences's overall financial performance and is widely used to measure a its profitability.

To put Cytek Biosciences's EBITDA into context you can compare it against that of similar companies.

Cytek Biosciences financials

Revenue TTM $148.5 million
Operating margin TTM 0.65%
Gross profit TTM $79.1 million
Return on assets TTM 0.17%
Return on equity TTM -0.88%
Profit margin -1.57%
Book value $3.05
Market capitalisation $1.7 billion

TTM: trailing 12 months

Cytek Biosciences share dividends

We're not expecting Cytek Biosciences to pay a dividend over the next 12 months.

Cytek Biosciences overview

Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries.

Frequently asked questions

What percentage of Cytek Biosciences is owned by insiders or institutions?
Currently 17.328% of Cytek Biosciences shares are held by insiders and 47.166% by institutions.
How many people work for Cytek Biosciences?
Latest data suggests 555 work at Cytek Biosciences.
When does the fiscal year end for Cytek Biosciences?
Cytek Biosciences's fiscal year ends in December.
Where is Cytek Biosciences based?
Cytek Biosciences's address is: 47215 Lakeview Boulevard, Fremont, CA, United States, 94538
What is Cytek Biosciences's ISIN number?
Cytek Biosciences's international securities identification number is: US23285D1090

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site